Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.
Centre for Advanced Studies, Research and Development in Sardinia (CRS4), Science and Technology Park Polaris, Pula (CA), Italy.
Am J Med Genet A. 2019 Apr;179(4):634-638. doi: 10.1002/ajmg.a.61052. Epub 2019 Feb 8.
We report here a novel de novo missense variant affecting the last amino acid of exon 30 of CREBBP [NM_004380, c.5170G>A; p.(Glu1724Lys)] in a 17-year-old boy presenting mild intellectual disability and dysmorphisms but not resembling the phenotype of classical Rubinstein-Taybi syndrome. The patient showed a marked overweight from early infancy on and had cortical heterotopias. Recently, 22 individuals have been reported with missense mutations in the last part of exon 30 and the beginning of exon 31 of CREBBP, showing this new phenotype. This additional case further delineates the genotype-phenotype correlations within the molecular and phenotypic spectrum of variants in CREBBP and EP300.
我们在此报告一例新的从头错义变异,影响 CREBBP [NM_004380,c.5170G>A;p.(Glu1724Lys)] exon30 的最后一个氨基酸,该变异发生在一名 17 岁男孩中,其表现为轻度智力障碍和发育异常,但与经典 Rubinstein-Taybi 综合征的表型不同。该患者从婴儿早期开始就明显超重,且存在皮质异位。最近,已有 22 例患者报道在 CREBBP 的 exon30 末段和 exon31 起始段发生错义突变,表现出这种新的表型。这例新增病例进一步阐明了 CREBBP 和 EP300 中变异的分子和表型谱内的基因型-表型相关性。